Anteris Technologies Global Corp.

AVR ·Healthcare, Medical Devices, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Apr 23, 2026 8-K
424B3 Mar 18, 2026 424B3
EFFECT Mar 13, 2026
POS AM Mar 10, 2026 POS AM
4 Mar 6, 2026 FORM 4
8-K Mar 3, 2026 8-K
8-K Feb 27, 2026 8-K
10-K Feb 26, 2026 10-K
SCHEDULE 13G/A Feb 13, 2026
4 Feb 9, 2026
SCHEDULE 13G/A Feb 5, 2026
SCHEDULE 13D Jan 29, 2026
3 Jan 29, 2026 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
424B3 Jan 23, 2026 424B3
8-K Jan 22, 2026 FORM 8-K
8-K Jan 22, 2026 8-K
424B5 Jan 22, 2026 424B5
SCHEDULE 13G/A Jan 21, 2026
FWP Jan 21, 2026 FWP
FWP Jan 20, 2026 FWP
424B5 Jan 20, 2026 424B5
EFFECT Jan 8, 2026
CORRESP Jan 6, 2026
UPLOAD Jan 6, 2026
S-3 Jan 2, 2026 S-3
← Newer Page 3 of 8 · 186 filings Older →